产品图片
货号/SKU
NR-2638
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质，其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类：美国、1
产品描述信息
NR-2638?? Genomic DNA from Vaccinia Virus, New York City Board of Health (Wyeth, Calf adapted) (Nucleic Acids)|Vaccinia virus|Genomic DNA from Vaccinia Virus, New York City Board of Health (Wyeth, Calf adapted) |-20°C or colder|ATCC?Acknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Genomic DNA from Vaccinia Virus, New York City Board of Health (Wyeth, Calf adapted), NR-2638."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Genomic DNA was isolated from a preparation of cell lysate and supernatant from cells infected with vaccinia virus, IHD (BEI Resources NR-54).
Lot 5075334 was prepared from infected Cercopithecus aethiops kidney epithelial cells (MA-104 Clone 1; ATCC ? CRL-2378.1?). Lot 63421353 was prepared from infected Cercopithecus aethiops kidney epithelial cells (Vero; ATCC ? CCL-81?).
The NYCBH (Wyeth, calf adapted) strain was derived from a strain obtained by the NYCBH by multiple passage in calf skin. It was used to develop Dryvax?, the live-virus vaccine used during both the World Health Organization vaccination program ending in the mid 1970s and the vaccination programs of the Department of Health and Human Services and Department of Defense which began in 2002.
NR-2638 has been qualified for PCR applications by amplification of either an approximately 2600 bp sequence or an approximately 1100 bp sequence. NR-2638 is not intended for use as a standard for quantitative PCR.
Each vial of lot 5075334 contains a target amount of 1 ×108 copies of viral genomic DNA in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.5) containing sodium azide. The actual number of copies per vial may vary from 10-fold lower to 10-fold higher.
Each vial of lot 63421353 contains 100 ?L of viral genomic DNA in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.0).
The viral genomic DNA is in a background of cellular nucleic acid and carrier RNA. The vial should be centrifuged prior to opening.
Genomic DNA was isolated from a preparation of cell lysate and supernatant from cells infected with vaccinia virus, IHD (BEI Resources NR-54).
Lot 5075334 was prepared from infected Cercopithecus aethiops kidney epithelial cells (MA-104 Clone 1; ATCC ? CRL-2378.1?). Lot 63421353 was prepared from infected Cercopithecus aethiops kidney epithelial cells (Vero; ATCC ? CCL-81?).
The NYCBH (Wyeth, calf adapted) strain was derived from a strain obtained by the NYCBH by multiple passage in calf skin. It was used to develop Dryvax?, the live-virus vaccine used during both the World Health Organization vaccination program ending in the mid 1970s and the vaccination programs of the Department of Health and Human Services and Department of Defense which began in 2002.
NR-2638 has been qualified for PCR applications by amplification of either an approximately 2600 bp sequence or an approximately 1100 bp sequence. NR-2638 is not intended for use as a standard for quantitative PCR.
Each vial of lot 5075334 contains a target amount of 1 ×108 copies of viral genomic DNA in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.5) containing sodium azide. The actual number of copies per vial may vary from 10-fold lower to 10-fold higher.
Each vial of lot 63421353 contains 100 ?L of viral genomic DNA in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.0).
The viral genomic DNA is in a background of cellular nucleic acid and carrier RNA. The vial should be centrifuged prior to opening.
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.此限制的订单将在发货前发送到NIAID进行批准. 基因组DNA从细胞裂解物的制备和从感染痘苗病毒感染的细胞中上清液（BEI资源NR-54 ）. 批量5075334由受感染的 Cercopithecus Aethiops（MA-104克隆1; ATCC ? CRL-2378.1?）制备.批次63421353由感染的感染者 Cercopithecus Aethiops 肾上皮细胞（Vero; ATCC ?CCL-81?）. NYCBH（WYETH，CALF适应）菌株衍生自肾性皮肤中的纽约核细胞获得的菌株.它用于开发Dryvax ?，其在20世纪70年代中期的世界卫生组织疫苗接种计划中使用的活病毒疫苗和卫生和人力服务部的疫苗接种计划以及国防部从2002年开始. NR-2638通过扩增约2600bp序列或约1100bp序列，NR-2638已获得PCR应用. NR-2638 不适用于定量PCR标准. 批次的每个小瓶包含1×10 8 副本的目标量Te缓冲液中的病毒基因组DNA（10mM Tris-HCl，1mM EDTA，pH7.5）含氧化钠.每个小瓶的实际拷贝数可以从下降到10倍到10倍. 批次的每个小瓶在Te缓冲液中含有100μl病毒基因组DNA（10mM Tris-HCl，1mm EDTA，pH 7.0）. 病毒基因组DNA在细胞核酸和载体RNA的背景中.在打开之前应该离心小瓶.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立，旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中，可以监控科学界对这些材料的访问和使用，并确保试剂的质量控制。
除了为传染病界提供材料外，BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势，包括安全存储、社区访问和分发；同时保护存款人的知识产权。只要有需要，BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月， ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料，包括由其他政府支持的研究项目存放的材料，将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中，涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2021-12-21
2021-12-02
2024-06-22
2022-03-31
2022-04-01
2023-11-14
2021-12-21
2022-04-01
2022-04-01
2021-12-21
2023-10-21
2021-12-21
2022-06-17
2022-04-01
2024-08-16